Kobayashi Yoshihisa

コバヤシヨシヒサ | Kobayashi Yoshihisa

Affiliation and department：

Research field (5)： Molecular biology , Tumor biology , Tumor biology , Tumor biology , Tumor diagnostics and therapeutics

Research theme for competitive and other funds (10)：

2023 - 2026 Drug resistance and antisense oligo treatment
2023 - 2026 Carcinogenesis approached from drug resistance
2023 - 2025 Splicing and carcinogenesis
2021 - 2024 Biomarkers for predicting pre-treatment acquisition of drug resistance through gene amplification
2022 - 2023 Validation of novel cancer therapeutic targets using antisense oligonucleotides

Show all

Papers (41)：

Hitomi Sumiyoshi Okuma, Hiroshi Yoshida, Yoshihisa Kobayashi, Motoko Arakaki, Chiharu Mizoguchi, Lina Inagaki, Pei Jye Voon, Adam Malik Bin Ismail, Hwoei Fen Soo Hoo, Suhana Yusak, et al. Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia. Cancer science. 2023. 114. 6. 2664-2673
Yoshihisa Kobayashi, Geoffrey R. Oxnard, Elizabeth F. Cohen, Navin R. Mahadevan, Joao V. Alessi, Yin P. Hung, Arrien A. Bertram, David E. Heppner, Mauricio F. Ribeiro, Karina P. Sacardo, et al. Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors. Nature Communications. 2022
Ryohei Yoshida, Maria Saigi, Tetsuo Tani, Benjamin F Springer, Hirofumi Shibata, Shunsuke Kitajima, Navin R Mahadevan, Marco Campisi, William Kim, Yoshihisa Kobayashi, et al. MET-induced CD73 restrains STING-mediated immunogenicity of EGFR-mutant lung cancer. Cancer research. 2022. 82. 21. 4079-4092
Masahiro Higashiyama, Yoshihisa Kobayashi, Jumpei Kashima, Yuji Muraoka, Hirokazu Watanabe, Masahiko Kusumoto, Shun-Ichi Watanabe, Yasushi Yatabe. Invasive Mucinous Adenocarcinoma of the Lung with a Mural Nodule-like Lesion. The American journal of surgical pathology. 2022
Ciric To, Tyler S Beyett, Jaebong Jang, William W Feng, Magda Bahcall, Heidi M Haikala, Bo H Shin, David E Heppner, Jaimin K Rana, Brittaney A Leeper, et al. An allosteric inhibitor against the therapy-resistant mutant forms of EGFR in non-small cell lung cancer. Nature cancer. 2022

ｍore...

MISC (7)：

小林祥久, 光冨徹哉. 【頭頸部がん、肺がん】肺がん治療における血管新生阻害剤の役割. 腫瘍内科. 2016. 17. 6. 659-664
小林祥久, 光冨徹哉. 【肺癌治療の新しい夜明け】肺癌のドライバー変異. 成人病と生活習慣病. 2016. 46. 4. 427-432
EGFR Mutation and Tyrosine Kinase Inhibitors : Perspective on Future Therapy for Individual. 2015. 70. 12. 2461-2468
小林祥久, 光冨徹哉. EGFR-TKI耐性とその克服 (特集最新の肺がん治療) -- (薬物療法のトピックス). 臨牀と研究. 2015. 92. 7. 892-895
Kobayashi Yoshihisa, Mitsudomi Tetsuya, Sakao Yukinori, Yatabe Yasushi. A Case of Recurrent Pulmonary Artery Intimal Sarcoma After Left Pneumonectomy. JJLC. 2015. 55. 4. 251-256

ｍore...

Books (11)：

胆と膵
医学図書出版 2023
呼吸器内科
科学評論社 2021
肺癌診療Q&A 第3版
中外医学社 2017
臨床腫瘍プラクティス
ヴァンメディカル 2017
Clinical Oncology
KAGAKU-HYORONSHA 2016

ｍore...

Education (2)：

2014 - 2017 Kindai University Graduate School of Medical Sciences. Ph.D.
2002 - 2008 Mie University. M.D. Faculty of Medicine

Work history (6)：

2021/01 - 現在 National Cancer Center Research Institute Molecular Pathology Staff Scientist
2018/04 - 2020/12 Dana-Farber Cancer Institute Medical Oncology Research Fellow
2014/04 - 2018/03 Kindai University Thoracic Surgery Assistant Professor
2012/04 - 2014/03 Aichi Cancer Center Hospital Thoracic Surgery Senior Resident
2010/04 - 2012/03 Aichi Cancer Center Hospital Thoracic Surgery Resident

Show all

Awards (12)：

2023 - Young Scientist Award of the Nucleic Acids Therapeutics Society of Japan
2023 - Kiyoko and Paul Bourdarie-Goto Scientific Prize -Special Award
2023 - The Young Scientists’ Award, The Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology
2023 - President Award, the 31st General Assembly of the Japan congress 6NC retreat session
2022 - Shinoi-Kawai Award of the Japan Lung Cancer Society

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page